In vitro skin permeability of different terbinafine hydrochloride formulations

European Journal of Inflammation

Volumn 6, Issue 3, 2008, Pages 135-140

  Pretorius, Ebasson ^a   Bouic, P J D ^a   Thebus, Q ^a   Kriek, W ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Absorption; Formulations; Human skin; In vitro; Terbinafine hydrochloride

Indexed keywords

GENERIC DRUG; METHANOL; PHOSPHATE BUFFERED SALINE; TERBINAFINE;

ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFUSION; DRUG ABSORPTION; DRUG DETERMINATION; DRUG EXPOSURE; DRUG FORMULATION; DRUG SAFETY; DRUG SCREENING; DRUG TISSUE LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFUSION SYSTEM; SKIN PERMEABILITY; TISSUE SECTION;

EID: 58149493034     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X0800600306     Document Type: Article

References (27)

1. Akomeah FK, Martin GP, Brown MB. Variability in human skin permeability in vitro: Comparing penetrants with different physiochemical properties. J Pharm Sci 2006; 96(4):824-34.
2. Moss GP, Dearden JC, Patel H, Cronin MTD. Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol In Vitr 2000; 16:299-317.
3. Córdoba-Diaz M, Nova M, Elorza B, Córdoba-Diaz D, Chantres JR, Córdoba-Borrego M. Validation protocol of an automated in-line flow-through diffusion equipment for in vitro permeation studies. J Control Release 2000; 69(3):357-67.
4. Hug MJ. Transepithelial measurements using the Ussing chamber. Provided through: The European Working Group on CFTR Expression. 2002; pp 1-10.
5. Schmook FP, Meingassner JG, Billich A. Comparison of human skin or epidermis models with human and animal skin in in vitro percutaneous absorption. Int J Pharm 2001; 215:51-6.
6. Collier SW, Storm JE, Bronaugh RL. Cutaneous metabolism. In In vitro percutaneous absorption: principles, fundamentals and applications. R.L. Bronaugh and H.I. Maibach, eds. CRC Press, Boca Raton, 1991; pp. 67-83.
7. Alberti I, Kalia YN, Naik A, Bonny J-D, Guy RH. Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo. Int J Pharm 2001; 219:11-19.
8. Schuster I, Schaude M, Shatz F et al. Preclinical characteristics of allylamines. In Sterol Biosynthesis inhibitors. D. Berg and M. Plempel, eds. Chichester: Ellis Horwood, 1988; pp. 449-70.
9. Yeganeh MH, McLachlan AJ. Determination of terbinafine in tissues. Biomed Chromatogr 2000; 14: 261-8.
10. Van der Bijl P, Van Eyk AD, Thompson IOC. Effect of freezing on the permeability of human buccal and vaginal mucosa. S Afr J Sci 1998; 94:499-502.
11. Van der Bijl P, Van Eyk AD, Seifart HI, De Jager F, Nel CMM. Diffusion of diclofenac and piroxicam from commercially available gels through human skin. SA J Physiotherapy 2003; 59:3-6.
12. Van Eyk AD, Van der Bijl P. Comparative permeability of various chemical markers through human vaginal and buccal mucosa as well as porcine buccal and mouth floor mucosa. Arch Oral Biol 2004; 49(5):387-92.
13. Basson E, Van der Bijl P, Van Eyk AD. Transvaginal diffusion of synthetic peptides. Eur J Inflamm 2007; 5(1):15-20.
14. Hadgraft J. Modulation of the barrier function of the skin. Skin Pharmacol Appl Skin Physiol.2001; 14(1): 72-81.
15. Goates CY, Knutson K. Enhanced permeability of polar compounds through human epidermis. I. Permeability and membrane structural changes in the presence of short chain alcohols. Biochim Biophys Acta (BBA) - Biomembranes 1994; 1195(1):169-79.
16. Dugard PH, Walker M, Mawdsley SJ, Robert CS. Absorption of some glycol ethers through human skin in vitro. Environ Health Perspect 1984; 57:193-7.
17. Nangia A, Patil S, Berner B, Boman A, Maibach H. In vitro measurement of transepidermal water loss: a rapid alternative to tritiated water permeation for assessing skin barrier functions. Int J Pharm 1998; 170(1):33-40.
18. Ho S, Calder RJ, Thomas CP, Heard CM. In vitro transcutaneous delivery of tamoxifen and gamma-linolenic acid from borage oil containing ethanol and 1,8-cineole. J Pharm Pharmacol 2004; 56:1357-64.
19. Femenia-Font A, Balaguer-Fernandez C, Merino V, Rodilla V, Lopez-Castellano A. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. Eur J Pharm Biopharm 2005; 61:50-5.
20. López-Pinto JM, González-Rodríguez ML, Rabasco AM. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 2005; 298(1):1-12.
21. Leyden J. Pharmacokinetics and pharmacology of terbinafine and itraconazole. J Am Acad Dermatol 1998; 38:42-7.
22. Tatsumi Y, Yokoo M, Senda H, Kakehi K. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine. Antimicrob Agents Chemother 2002; 46(12):3797-801.
23. Uchida K, Yamaguguchi H. Studies on the affinity of terbinafine with keratin. Jpn J Med Mycol 1993; 34: 207-12.
24. Dugard PH. Skin permeability theory in relation to measurements of percutaneous absorption in toxicology. In Dermatotoxicology and pharmacology. F.N. Marzulli and H.I. Maibach eds. Hemisphere Publishing Corporation, Washington, 1977; pp. 525-50.
25. James IG, Loria-Kanza Y, Jones TC. Short-duration topical treatment of tinea pedis using terbinafine emulsion gel: Results of a dose ranging clinical trial. J Dermatol Treat 2007; 18:163-168.
26. Cramer J, Kshatriya B, Snoddy A. Skin pharmacokinetics of terbinafine in healthy subjects following once-daily application of 1% emulsion gel or 1% cream for 1, 5 or 7 days. In: Meeting guide and abstracts of the 2006 Annual Meeting of the American College of Clinical Pharmacy, St Louis, MO, Abstract 249, 2006.
27. Hadgraff J, Whitefield M, Rosher PH. Skin Penetration of Topical Formulations of Ibuprofen 5%: An in vitro Comparative Study. Skin Pharmacol Appl Skin Physiol 2003; 16:137-42.